+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Needle-Free Drug Delivery Devices Market 2019-2025

  • ID: 5116763
  • Report
  • February 2020
  • Region: Asia Pacific
  • Orion Market Research Private Limited
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M Co.
  • Enesi Pharma Ltd.
  • Ferring Holdings SA
  • GlaxoSmithKline PLC
  • Novartis AG
  • MORE
Asia-Pacific Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report, By Technology (Inhaler Technology, Jet Injectors, Transdermal Patch Technology, and Others), By Application (Vaccines Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Others), and Forecast 2019-2025.

The Asia-Pacific needle-free drug delivery devices market is expected to grow at a CAGR of around 15% during the forecast period. The increasing need for self-administration of drugs as in the case of diseases such as diabetes and benefits offered by this technology such as pain-free drug delivery has enhanced the size of needle-free drug delivery devices industry. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by biotechnology companies coupled with harnessing innovation.

The rising prevalence of chronic respiratory diseases coupled with the increasing geriatric population and increasing technological advancement are the major factors that drive the growth of needle-free drug delivery devices market in Asia-Pacific. The Asia-Pacific needle-free drug delivery devices market is segmented on the basis of technology and application. Based on the technology, the market is segmented into inhaler technology, jet injectors, transdermal patch technology, others. Jet injectors are used for a broad range of applications due to their benefits such as rapid administration, faster response rates, and improved dosing accuracy. In addition, these devices offer better diffusion into tissues and are easily portable. Further, on the basis of application, the market is segmented into pain management, insulin delivery, vaccine delivery, pediatric injections, and others.

Further,

The Report Covers:

the analysis of several players operating in the market. Some of the key players operating in the market include 3M Co., Boerhinger Ingelheim International GmbH, Enesi Pharma Ltd., Novartis AG, GlaxoSmithKline PLC, Ferring Holding SA, and others.

Research Methodology:

The market study of the Asia-Pacific needle-free drug delivery devices market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, investing companies and venture capitalists, hospitals and clinics, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Asia-Pacific Needle-Free Drug Delivery Devices Market Research and Analysis by Technology
2. Asia-Pacific Needle-Free Drug Delivery Devices Market Research and Analysis by Application
Note: Product cover images may vary from those shown
2 of 2
  • 3M Co.
  • Boerhinger Ingelheim International GmbH
  • Enesi Pharma Ltd.
  • Ferring Holdings SA
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll